首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Discover oncology

缩写:

ISSN:N/A

e-ISSN:2730-6011

IF/分区:2.9/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引3835
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yunfei Sun,Bo Liu,Xuan Zhang et al. Yunfei Sun et al.
Background: HER2-positive breast cancer, known for its heterogeneity and complex molecular mechanisms, poses a significant therapeutic challenge. Lidocaine, a widely used local anesthetic, has recently been identified as ...
Yibin Zheng,Hang Cai,Hongbin Huang et al. Yibin Zheng et al.
Disulfidptosis was reported to be associated with the malignant progression of various tumors. This study was aimed to investigate the prognostic significance of disulfidptosis-related genes (DRGs) in osteosarcoma (OS). Ten previously repor...
Meiqin Shi,Ping Song,Kun Du et al. Meiqin Shi et al.
Purpose: To determine the incidence, severity and risk factors of complications in patients undergoing laryngectomy. Methods: 433 patie...
Xianhua Han,Junyu Qiu Xianhua Han
Introduction: Endometrial cancer (EC) is a common gynecologic malignancy with increasing incidence and notable molecular heterogeneity. This study aimed to develop a non-invasive, cost-effective prognostic model using pat...
Mingpeng Cao,Ying Tang,Razzagh Abedi-Firouzjah et al. Mingpeng Cao et al.
Background: Stomach cancer, or gastric cancer (GC), is a major global health problem characterized by the malignant proliferation of cells in the gastrointestinal lining. Recent studies have highlighted the potential ther...
Tatsuya Yoshida,Kozo Kuribayashi Tatsuya Yoshida
In August 2018, Japan's Pharmaceuticals and Medical Devices Agency (PMDA) became the first in the world to approve immune checkpoint inhibitor (ICI) monotherapy with nivolumab for previously treated, unresectable, advanced, or recurrent ple...
Zhangdi Yan,Lixin Du,Xiaotong Zhang et al. Zhangdi Yan et al.
Cholangiocarcinoma (CCA) is a highly aggressive malignancy with an extremely poor prognosis. The rising incidence of cholangiocarcinoma in recent years underscores the need for new diagnostic biomarkers and therapeutic targets. Circular RNA...